Eton Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Eton Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ETON
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001710340
Board of directors
-
Charles J. Casamento · DirectorSince 2023
-
Jennifer McKie Adams · DirectorSince 2023
-
Norbert G. Riedel · DirectorSince 2023
-
Paul Maier V · DirectorSince 2023
-
Sean Brynjelsen · Director · President & CEOSince 2023
Chief executives
Sean Brynjelsen
· President & CEO
Dates unknown
Board connections
2 of this board's directors also sit on 4 other boards.
- via Charles J. Casamento
- via Charles J. Casamento
- via Norbert G. Riedel
- via Charles J. Casamento
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 2024 | Opaleye Management Inc. 10% owner | Open-market purchase | +10,000 | $7.98 | $79,800 |
| Oct 8, 2024 | Opaleye Management Inc. 10% owner | Open-market purchase | +30,000 | $7.03 | $210,900 |
| Oct 8, 2024 | Opaleye Management Inc. 10% owner | Open-market purchase | +3,970 | $7.03 | $27,909 |
| Oct 7, 2024 | Opaleye Management Inc. 10% owner | Open-market purchase | +10,000 | $7.22 | $72,200 |
| Oct 7, 2024 | Opaleye Management Inc. 10% owner | Open-market purchase | +1,248 | $7.22 | $9,011 |
| Oct 4, 2024 | Opaleye Management Inc. 10% owner | Open-market purchase | +15,000 | $6.77 | $101,550 |
| Oct 4, 2024 | Opaleye Management Inc. 10% owner | Open-market purchase | +1,852 | $6.77 | $12,538 |
| Sep 11, 2024 | Opaleye Management Inc. 10% owner | Open-market purchase | +45,000 | $4.75 | $213,750 |
| Sep 11, 2024 | Opaleye Management Inc. 10% owner | Open-market purchase | +5,000 | $4.75 | $23,750 |
| Sep 10, 2024 | Opaleye Management Inc. 10% owner | Open-market purchase | +50,000 | $4.65 | $232,500 |
| Sep 10, 2024 | Opaleye Management Inc. 10% owner | Open-market purchase | +7,500 | $4.65 | $34,875 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.